Related Experiment Videos
Ergocryptine and pregnancy maintenance in hamsters.
Summary
Ergocryptine (ECR) terminates hamster pregnancy early, but its effect is blocked by prolactin. Later pregnancy stages show reduced prolactin support, suggesting a placental luteotrophin emerges.
Area of Science:
- Reproductive Endocrinology
- Developmental Biology
- Hormone Action
Background:
- Ergocryptine (ECR) is known to interfere with reproductive processes.
- The role of pituitary hormones like prolactin, FSH, and LH in maintaining pregnancy varies across species and gestation stages.
- Understanding hormonal shifts during pregnancy is crucial for identifying potential luteotrophic factors.
Purpose of the Study:
- To investigate the effects of Ergocryptine (ECR) on pregnancy termination in hamsters at different gestational days.
- To determine the role of prolactin, FSH, and LH in counteracting ECR's abortifacient effects.
- To identify potential luteotrophic activities in hamster sera during gestation.
Main Methods:
- Administration of Ergocryptine (ECR) to pregnant hamsters on Days 5, 6, and 7 of gestation.
- Treatment with exogenous prolactin, FSH, and LH to assess their ability to overcome ECR-induced termination.
- Assay of hamster sera collected on various gestation days for luteotrophic activity neutralization of ECR's effects.
Main Results:
- ECR terminated pregnancy effectively when given on Day 5, with diminished effects on Day 6 and no effect on Day 7.
- Exogenous prolactin successfully prevented ECR-induced abortion in Day 5 pregnant hamsters, while FSH and LH did not.
- A peak in luteotrophic activity was detected in sera from Days 10 and 11 of gestation, capable of neutralizing ECR.
Conclusions:
- Pituitary prolactin's role in luteal support diminishes by Day 7 of hamster pregnancy.
- The luteotrophic activity observed in mid-gestation sera suggests the emergence of a placental luteotrophin.
- This study highlights dynamic hormonal changes critical for successful pregnancy maintenance in hamsters.